Medical Marketing and Media

RSS | Login | Register

Professional Marketing Articles

Millennium CEO: pharma needs focus

Deborah Weinstein May 01, 2012

The drug industry is struggling with more than expiring patents and shrinking sales forces, Millennium Pharmaceuticals CEO Deborah Dunsire told industry watchers in March. Rather, it's wrestling with a top-to-bottom revolution

Study shows gender gap in prescriptions and treatment

Deborah Weinstein May 01, 2012

Women are simultaneously given more drugs than men and undertreated, according to a study by Medco and the Society of Women's Health Research.

Professional Marketing briefs: May 2012

Deborah Weinstein May 01, 2012

News on Daiichi Sankyo, Delta Point, Doctor Insights and Corcept Therapeutics

IFPMA code draws clear boundaries

Deborah Weinstein April 01, 2012

For those poring over the Sunshine Act's fine print, the latest code of conduct guidelines from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) will seem mellow.

Drug samples falling out of favor as pharma sales tool

Deborah Weinstein April 01, 2012

Cegedim Strategic Data found a 25% dip in industry support for samples bewteen 2007 and 2011—from just under $8.5 billion to about $6 billion.

Professional Marketing briefs: April 2012

Deborah Weinstein April 01, 2012

News on GlaxoSmithKline, Daiichi Sankyo, Columbia Laboratories and Eli Lilly

AstraZeneca to cut 7,300 more jobs

Deborah Weinstein March 01, 2012

AstraZeneca confirmed rumors of another round of deep cuts, announcing that it will eliminate 7,300 positions.

Solicitor General sides with reps in GSK overtime case

Deborah Weinstein March 01, 2012

The U.S. Solicitor General has filed an amicus brief taking the side of two pharmaceutical sales reps in the overtime case that they filed against GlaxoSmithKline.

Professional Marketing briefs—March 2012

Deborah Weinstein March 01, 2012

News on D&R Communications, Publicis Touchpoint Solutions, Santarus and Physicians Interactive

Novartis cuts jobs to counter losses

Matthew Arnold February 01, 2012

Novartis will eliminate 1,630 sales rep jobs and 330 headquarters marketing jobs as its hypertension franchise faces the impending loss of Diovan patent exclusivity and the impact of ugly study results on Tekturna sales.

« Previous

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.